Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1964 1
1979 1
1982 1
1984 1
1985 5
1986 6
1987 9
1988 5
1989 12
1990 14
1991 6
1992 15
1993 14
1994 11
1995 5
1996 5
1997 11
1998 17
1999 13
2000 10
2001 18
2002 29
2003 25
2004 25
2005 41
2006 39
2007 32
2008 45
2009 32
2010 28
2011 31
2012 30
2013 33
2014 39
2015 20
2016 27
2017 26
2018 26
2019 28
2020 39
2021 45
2022 36
2023 38
2024 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

836 results

Results by year

Filters applied: . Clear all
Page 1
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K. Yamaguchi M, et al. Among authors: matsuno y. J Clin Oncol. 2009 Nov 20;27(33):5594-600. doi: 10.1200/JCO.2009.23.8295. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805668 Clinical Trial.
ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in mice.
Yoshida K, Morishima Y, Ano S, Sakurai H, Kuramoto K, Tsunoda Y, Yazaki K, Nakajima M, Sherpa MT, Matsuyama M, Kiwamoto T, Matsuno Y, Ishii Y, Hayashi A, Matsuzaka T, Shimano H, Hizawa N. Yoshida K, et al. Among authors: matsuno y. J Allergy Clin Immunol. 2023 Apr;151(4):1067-1080.e9. doi: 10.1016/j.jaci.2022.12.808. Epub 2022 Dec 30. J Allergy Clin Immunol. 2023. PMID: 36592705
Morphea-like subcutaneous panniculitis-like T-cell lymphoma.
Tokuchi K, Yanagi T, Inamura E, Kawamura T, Seo T, Fujita Y, Nakagawa M, Kasahara I, Matsuno Y, Ujiie H. Tokuchi K, et al. Among authors: matsuno y. JAAD Case Rep. 2024 Feb 10;46:27-29. doi: 10.1016/j.jdcr.2023.12.025. eCollection 2024 Apr. JAAD Case Rep. 2024. PMID: 38510836 Free PMC article. No abstract available.
Arginase 2 attenuates ulcerative colitis by antioxidant effects of spermidine.
Imazu N, Torisu T, Yokote A, Umeno J, Kawasaki K, Fujioka S, Matsuno Y, Nagasue T, Kawatoko S, Moriyama T, Nitahata T, Uchida Y, Aihara S, Taniguchi Y, Oda Y, Kitazono T. Imazu N, et al. Among authors: matsuno y. J Gastroenterol. 2024 Aug;59(8):682-698. doi: 10.1007/s00535-024-02104-z. Epub 2024 May 2. J Gastroenterol. 2024. PMID: 38695904
Supported Molecular Matrix Electrophoresis.
Matsuno YK, Kameyama A. Matsuno YK, et al. Methods Mol Biol. 2015;1314:303-11. doi: 10.1007/978-1-4939-2718-0_31. Methods Mol Biol. 2015. PMID: 26139278
A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency.
Kohsaka S, Yagishita S, Shirai Y, Matsuno Y, Ueno T, Kojima S, Ikeuchi H, Ikegami M, Kitada R, Yoshioka KI, Toshimitsu K, Tabata K, Yokoi A, Doi T, Yamamoto N, Owa T, Hamada A, Mano H. Kohsaka S, et al. Among authors: matsuno y. NPJ Precis Oncol. 2024 May 24;8(1):117. doi: 10.1038/s41698-024-00610-0. NPJ Precis Oncol. 2024. PMID: 38789724 Free PMC article.
GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway.
Ikeuchi H, Matsuno Y, Kusumoto-Matsuo R, Kojima S, Ueno T, Ikegami M, Kitada R, Sumiyoshi-Okuma H, Kojima Y, Yonemori K, Yatabe Y, Takamochi K, Suzuki K, Yoshioka KI, Mano H, Kohsaka S. Ikeuchi H, et al. Among authors: matsuno y. Oncogene. 2024 Oct;43(41):3037-3048. doi: 10.1038/s41388-024-03105-1. Epub 2024 Aug 3. Oncogene. 2024. PMID: 39095584
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Watanabe T, Tobinai K, Wakabayashi M, Maruyama D, Yamamoto K, Kubota N, Shimada K, Asagoe K, Yamaguchi M, Ando K, Ogura M, Kuroda J, Suehiro Y, Matsuno Y, Tsukasaki K, Nagai H. Watanabe T, et al. Among authors: matsuno y. Br J Haematol. 2024 Mar;204(3):849-860. doi: 10.1111/bjh.19213. Epub 2023 Nov 23. Br J Haematol. 2024. PMID: 37996986 Clinical Trial.
836 results